Effectiveness of Rehabilitation on the Recovery of Patients Post Right Stroke With Unilateral Spatial Neglect

NCT ID: NCT00305513

Last Updated: 2010-06-03

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: PHASE2
• Total Enrollment: 6 participants
• Study Classification: INTERVENTIONAL

Brief Summary

Unilateral spatial neglect (USN) is believed to be a disorder of attention, characterized by impairment in the ability to perceive or respond to stimuli presented to the contralesional space, and which is not attributable to significant sensory or motor deficits. USN has serious consequences for rehabilitation and long term disabilities. Efforts have been made to clarify both the theoretical basis of this phenomenon and the rehabilitation methods that will be best in improving function. The purpose of this study is to try and contribute to both efforts by examining treatment effectiveness of two methods; one targeting general arousal (phasic alerting), and the other targeting increasing awareness to left side stimuli and habit changes. Functional neuroimaging methods (PET [positron emission tomography] and fMRI [functional magnetic resonance imaging]) have been applied to understand the functional anatomy of the brain during mental processes. Only a few attempts have been made to use functional neuroimaging in patients with neurological deficits such as USN, usually speculations are made based on findings with healthy participants to explain this disorder. This study's aim is to examine the functional reorganization of the attentional network in the brain of USN patients while performing visual tasks, by means of functional neuroimaging techniques, in light of specific rehabilitation techniques.

Patients will be examined before and after 3 weeks of rehabilitation both using standardized neurobehavioral tests and PET imaging procedures.

Detailed Description

Procedure:

Inclusion criteria:

• first time right hemispheric stroke (ischemic);
• 2-6 weeks post stroke incident;
• ages 25-85;
• right hand dominance;
• minimum education of 6 years;
• do not suffer from field cut deficit such as hemi-anopsia;
• without other known neurological disorders (e.g., Parkinson's disease, aphasia);
• without severe systemic conditions (e.g., malignancies, AIDS, congestive heart failure, substance abuse);
• did not take additional medications that could affect the central nervous system; without dementia;
• without mental illness;
• the patients or their legal guardians have to give informed consent.

Participants:

• six patients will be recruited and randomly allocated to one of the treatment groups (phasic alerting or standard visual spatial training treatment provided in the OT department).

Patients will undergo thorough evaluation of neglect and will undergo PET procedure before being transferred to rehabilitation. Patient will receive intensive rehabilitation for 15 sessions of the cognitive treatment and 15 session of motor training. After this period patient will undergo another PET procedure to assess any changes in brain activation. Patient will then return to rehabilitation as needed.

Conditions

Cerebrovascular Accident; Perceptual Disorders

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Interventions

The phasic alerting treatment

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• First time right hemispheric stroke (ischemic)
• 2 - 6 weeks post stroke incident
• Ages 25 - 85
• Right hand dominance
• Minimum education of 6 years
• The patients or their legal guardians have to give informed consent
• Does not suffer from field cut deficit such as hemi-anopsia
• Without other known neurological disorders (e.g., Parkinson's disease, aphasia)
• Without severe systemic conditions (e.g., malignancies, AIDS, congestive heart failure, substance abuse)
• Does not take additional medications that could affect the central nervous system
• Without dementia
• Without mental illness

• Minimum Eligible Age: 25 Years
• Maximum Eligible Age: 85 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Hadassah Medical Organization

OTHER

Sponsor Role: lead

Principal Investigators

Zeev Meiner, MD

Role: PRINCIPAL_INVESTIGATOR

Hadassah Medical Organization

Locations

Hadassah Medical Organization

Jerusalem, , Israel

Countries

Israel

Central Contacts

Zeev Meiner, MD

Role: CONTACT

MEINER@hadassah.org.il

00 972 2 5844582

Facility Contacts

Arik Tzukert, DMD

Role: primary

arik@hadassah.org.il

00 972 2 6776095

Other Identifiers

10-17.02.06-HMO-CTIL

Identifier Type: -

Identifier Source: org_study_id